CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) Return on equity 2021–2025
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-27.7%FY2025 · since FY2021: -109.8% → -27.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -27.7% | -15.1 pp |
| FY2024 | -12.6% | +61.9 pp |
| FY2023 | -74.5% | +20.4 pp |
| FY2022 | -94.9% | +14.8 pp |
| FY2021 | -109.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice